Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

WRD vs RBOT vs NVDA vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WRD
WeRide Inc.

Software - Infrastructure

TechnologyNASDAQ • CN
Market Cap$2.40B
5Y Perf.-50.0%
RBOT
Vicarious Surgical Inc.

Medical - Devices

HealthcareNYSE • US
Market Cap$3M
5Y Perf.-93.8%
NVDA
NVIDIA Corporation

Semiconductors

TechnologyNASDAQ • US
Market Cap$5.14T
5Y Perf.+59.3%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.-10.0%

WRD vs RBOT vs NVDA vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WRD logoWRD
RBOT logoRBOT
NVDA logoNVDA
ISRG logoISRG
IndustrySoftware - InfrastructureMedical - DevicesSemiconductorsMedical - Instruments & Supplies
Market Cap$2.40B$3M$5.14T$161.07B
Revenue (TTM)$361M$0.00$215.94B$10.58B
Net Income (TTM)$-2.52B$-42M$120.07B$2.98B
Gross Margin30.7%71.1%66.3%
Operating Margin-6.1%60.4%30.5%
Forward P/E25.6x43.8x
Total Debt$143M$8M$11.41B$303M
Cash & Equiv.$4.27B$3M$10.61B$3.37B

WRD vs RBOT vs NVDA vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WRD
RBOT
NVDA
ISRG
StockOct 24May 26Return
WeRide Inc. (WRD)10050.0-50.0%
Vicarious Surgical … (RBOT)1006.2-93.8%
NVIDIA Corporation (NVDA)100159.3+59.3%
Intuitive Surgical,… (ISRG)10090.0-10.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: WRD vs RBOT vs NVDA vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NVDA leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Intuitive Surgical, Inc. is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
WRD
WeRide Inc.
The Specific-Use Pick

WRD plays a supporting role in this comparison — it may shine differently against other peers.

Best for: technology exposure
RBOT
Vicarious Surgical Inc.
The Secondary Option

RBOT lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
NVDA
NVIDIA Corporation
The Growth Play

NVDA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 65.5%, EPS growth 66.7%, 3Y rev CAGR 100.0%
  • 239.0% 10Y total return vs ISRG's 5.5%
  • PEG 0.27 vs ISRG's 2.01
  • 65.5% revenue growth vs WRD's -10.1%
Best for: growth exposure and long-term compounding
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • beta 1.02
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
  • Beta 1.02, current ratio 4.87x
  • Beta 1.02 vs WRD's 2.87, lower leverage
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthNVDA logoNVDA65.5% revenue growth vs WRD's -10.1%
ValueNVDA logoNVDALower P/E (25.6x vs 43.8x), PEG 0.27 vs 2.01
Quality / MarginsNVDA logoNVDA55.6% margin vs WRD's -7.0%
Stability / SafetyISRG logoISRGBeta 1.02 vs WRD's 2.87, lower leverage
DividendsNVDA logoNVDA0.0% yield; 2-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)NVDA logoNVDA+80.7% vs RBOT's -94.1%
Efficiency (ROA)NVDA logoNVDA58.1% ROA vs RBOT's -164.5%, ROIC 81.8% vs -116.2%

WRD vs RBOT vs NVDA vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WRDWeRide Inc.
FY 2024
Services
75.7%$273M
Products
24.3%$88M
RBOTVicarious Surgical Inc.

Segment breakdown not available.

NVDANVIDIA Corporation
FY 2026
Data Center
89.7%$193.7B
Gaming
7.4%$16.0B
Professional Visualization
1.5%$3.2B
Automotive
1.1%$2.3B
OEM And Other
0.3%$619M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

WRD vs RBOT vs NVDA vs ISRG — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNVDALAGGINGISRG

Income & Cash Flow (Last 12 Months)

NVDA leads this category, winning 6 of 6 comparable metrics.

NVDA and RBOT operate at a comparable scale, with $215.9B and $0 in trailing revenue. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to WRD's -7.0%. On growth, NVDA holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWRD logoWRDWeRide Inc.RBOT logoRBOTVicarious Surgica…NVDA logoNVDANVIDIA CorporationISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$361M$0$215.9B$10.6B
EBITDAEarnings before interest/tax-$42M$133.2B$3.8B
Net IncomeAfter-tax profit-$42M$120.1B$3.0B
Free Cash FlowCash after capex-$40M$96.7B$2.8B
Gross MarginGross profit ÷ Revenue+30.7%+71.1%+66.3%
Operating MarginEBIT ÷ Revenue-6.1%+60.4%+30.5%
Net MarginNet income ÷ Revenue-7.0%+55.6%+28.2%
FCF MarginFCF ÷ Revenue-188.0%+44.8%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+73.2%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+58.1%+97.8%+18.8%
NVDA leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

NVDA leads this category, winning 4 of 7 comparable metrics.

At 43.2x trailing earnings, NVDA trades at a 25% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), NVDA offers better value at 0.45x vs ISRG's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricWRD logoWRDWeRide Inc.RBOT logoRBOTVicarious Surgica…NVDA logoNVDANVIDIA CorporationISRG logoISRGIntuitive Surgica…
Market CapShares × price$2.4B$3M$5.14T$161.1B
Enterprise ValueMkt cap + debt − cash$1.8B$8M$5.14T$158.0B
Trailing P/EPrice ÷ TTM EPS-5.50x-0.06x43.16x57.62x
Forward P/EPrice ÷ next-FY EPS est.25.55x43.84x
PEG RatioP/E ÷ EPS growth rate0.45x2.65x
EV / EBITDAEnterprise value multiple38.59x43.62x
Price / SalesMarket cap ÷ Revenue45.14x23.80x16.00x
Price / BookPrice ÷ Book value/share1.96x0.30x32.85x9.17x
Price / FCFMarket cap ÷ FCF53.17x64.67x
NVDA leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

NVDA leads this category, winning 5 of 9 comparable metrics.

NVDA delivers a 76.3% return on equity — every $100 of shareholder capital generates $76 in annual profit, vs $-3 for RBOT. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to RBOT's 0.79x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs RBOT's 1/9, reflecting solid financial health.

MetricWRD logoWRDWeRide Inc.RBOT logoRBOTVicarious Surgica…NVDA logoNVDANVIDIA CorporationISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity-125.4%-3.3%+76.3%+16.9%
ROA (TTM)Return on assets-37.8%-164.5%+58.1%+14.8%
ROICReturn on invested capital-55.7%-116.2%+81.8%+15.0%
ROCEReturn on capital employed-104.7%-134.6%+97.2%+16.5%
Piotroski ScoreFundamental quality 0–92146
Debt / EquityFinancial leverage0.02x0.79x0.07x0.02x
Net DebtTotal debt minus cash-$4.1B$5M$807M-$3.1B
Cash & Equiv.Liquid assets$4.3B$3M$10.6B$3.4B
Total DebtShort + long-term debt$143M$8M$11.4B$303M
Interest CoverageEBIT ÷ Interest expense-780.14x545.03x
NVDA leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NVDA leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in NVDA five years ago would be worth $142,893 today (with dividends reinvested), compared to $16 for RBOT. Over the past 12 months, NVDA leads with a +80.7% total return vs RBOT's -94.1%. The 3-year compound annual growth rate (CAGR) favors NVDA at 93.6% vs RBOT's -80.2% — a key indicator of consistent wealth creation.

MetricWRD logoWRDWeRide Inc.RBOT logoRBOTVicarious Surgica…NVDA logoNVDANVIDIA CorporationISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-21.3%-80.6%+12.0%-19.3%
1-Year ReturnPast 12 months-11.1%-94.1%+80.7%-15.4%
3-Year ReturnCumulative with dividends-55.3%-99.2%+625.9%+49.6%
5-Year ReturnCumulative with dividends-55.3%-99.8%+1328.9%+58.7%
10-Year ReturnCumulative with dividends-55.3%-99.8%+23902.3%+554.2%
CAGR (3Y)Annualised 3-year return-23.6%-80.2%+93.6%+14.4%
NVDA leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NVDA and ISRG each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than WRD's 2.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 97.6% from its 52-week high vs RBOT's 3.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWRD logoWRDWeRide Inc.RBOT logoRBOTVicarious Surgica…NVDA logoNVDANVIDIA CorporationISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5002.87x1.92x1.73x1.02x
52-Week HighHighest price in past year$12.55$13.75$216.80$603.88
52-Week LowLowest price in past year$6.00$0.35$112.28$427.84
% of 52W HighCurrent price vs 52-week peak+58.9%+3.6%+97.6%+75.1%
RSI (14)Momentum oscillator 0–10050.130.060.742.4
Avg Volume (50D)Average daily shares traded4.3M24K164.5M1.8M
Evenly matched — NVDA and ISRG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: NVDA as "Buy", ISRG as "Buy". Consensus price targets imply 136.8% upside for WRD (target: $18) vs 31.8% for NVDA (target: $279).

MetricWRD logoWRDWeRide Inc.RBOT logoRBOTVicarious Surgica…NVDA logoNVDANVIDIA CorporationISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$17.50$278.83$622.60
# AnalystsCovering analysts7955
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$0.04
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.8%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

NVDA leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.

Best OverallNVIDIA Corporation (NVDA)Leads 4 of 6 categories
Loading custom metrics...

WRD vs RBOT vs NVDA vs ISRG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is WRD or RBOT or NVDA or ISRG a better buy right now?

For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.

5% revenue growth year-over-year, versus -10. 1% for WeRide Inc. (WRD). NVIDIA Corporation (NVDA) offers the better valuation at 43. 2x trailing P/E (25. 6x forward), making it the more compelling value choice. Analysts rate NVIDIA Corporation (NVDA) a "Buy" — based on 79 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WRD or RBOT or NVDA or ISRG?

On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 43.

2x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, NVIDIA Corporation is actually cheaper at 25. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0. 27x versus Intuitive Surgical, Inc. 's 2. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — WRD or RBOT or NVDA or ISRG?

Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1329%, compared to -99.

8% for Vicarious Surgical Inc. (RBOT). Over 10 years, the gap is even starker: NVDA returned +239. 0% versus RBOT's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WRD or RBOT or NVDA or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus WeRide Inc. 's 2. 87β — meaning WRD is approximately 182% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 79% for Vicarious Surgical Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — WRD or RBOT or NVDA or ISRG?

By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.

5% versus -10. 1% for WeRide Inc. (WRD). On earnings-per-share growth, the picture is similar: NVIDIA Corporation grew EPS 66. 7% year-over-year, compared to -24. 0% for WeRide Inc.. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WRD or RBOT or NVDA or ISRG?

NVIDIA Corporation (NVDA) is the more profitable company, earning 55.

6% net margin versus -696. 9% for WeRide Inc. — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus -605. 1% for WRD. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WRD or RBOT or NVDA or ISRG more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0. 27x versus Intuitive Surgical, Inc. 's 2. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NVIDIA Corporation (NVDA) trades at 25. 6x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 18. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WRD: 136. 8% to $17. 50.

08

Which pays a better dividend — WRD or RBOT or NVDA or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is WRD or RBOT or NVDA or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). WeRide Inc. (WRD) carries a higher beta of 2. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, WRD: -55. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WRD and RBOT and NVDA and ISRG?

These companies operate in different sectors (WRD (Technology) and RBOT (Healthcare) and NVDA (Technology) and ISRG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: WRD is a small-cap quality compounder stock; RBOT is a small-cap quality compounder stock; NVDA is a mega-cap high-growth stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

WRD

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Gross Margin > 18%
Run This Screen
Stocks Like

RBOT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

NVDA

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 36%
  • Net Margin > 33%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.